Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Not yet recruiting

Zanubrutinib and Sonrotoclax for the Treatment of Relapsed Chronic Lymphocytic Leukemia /Small Lymphocytic Leukemia, ZeuS-2 Trial

NCT07812246

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope at Irvine Lennar Irvine, California, United States

City of Hope Atlanta Cancer Center Newnan, Georgia, United States

View Trial Details

Not yet recruiting

HP-001 Plus Dexamethasone for Relapsed/Refractory Multiple Myeloma With Extramedullary Disease

NCT07811986

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences, Tianjin, 300000 Tianjin, China

View Trial Details

Not yet recruiting

BV-CHP Real-life and Biological Evidences in Patients With sALCL

NCT07467317

Conditions: Anaplastic Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: A.O.R.N. S. Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico Avellino, Italy

I.R.C.C.S. Centro di Riferimento Oncologico - S.O.C. Oncologia medica e dei tumori immuno-correlati Aviano, Italy

I.R.C.C.S. Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia Bari, Italy

A.S.S.T Papa Giovanni XXIII - S.C. Ematologia Bergamo, Italy

View all 19 locations

View Trial Details

Not yet recruiting

VR-PAT and fNIRS to Identify CNS Biomarkers of Pain

NCT06303687

Conditions: Acute Pain, Burns, Hematologic Diseases, +18 more
Locations: Nationwide Children's Hospital Columbus, Ohio, United States

View Trial Details

Not yet recruiting

Validating DW-MRI and Fat Fraction in Multiple Myeloma Post-ASCT: The RAC-FAT Study"

NCT07746232

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: IRCCS Istituto Tumori "G. Paolo II - U.O.C. Ematologia e Terapia Cellulare Bari, Italy

A.O.U. di Bologna - Policlinico S. Orsola Malpighi Bologna, Italy

A.O. Spedali Civili di Brescia Brescia, Italy

Istituto Oncologico Veneto IRCCS - UOC Oncoematologia Castelfranco Veneto, Italy

View Trial Details

Not yet recruiting

Prevention of Oral Mucositis in Adults in With Hematologic Malignancy

NCT07809984

Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +17 more
Locations: Advocate Christ Medical Center Oak Lawn, Illinois, United States

Advocate Lutheran General Park Ridge, Illinois, United States

Aurora St. Luke's Medical Center Milwaukee, Wisconsin, United States

View Trial Details

Not yet recruiting

A Randomized, Open-Label, Multicenter Phase III Clinical Study of JS203 Plus Chemotherapy Versus Rituximab Plus Chemotherapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT07808827

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Not yet recruiting

D2 - Isa-Iber-VD Induction, Followed by Risk & Response Adapted Consolidation & Maintenance, in Transplant-Eligible NDMM

NCT07624513

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Not yet recruiting

Tumour Immune and Ki-67 Scoring Methods as Prognostic Biomarkers in Diffuse Large B-cell Lymphoma and Aggressive B-cell Lymphomas

NCT07804173

Conditions: Diffuse Large B-cell Lymphoma and Aggressive B-cell Lymphomas, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Sohag university Sohag, Egypt

View Trial Details

Not yet recruiting

Isatuximab, Iberdomide, Bortezomib, Dexamethasone in Transplant Ineligible/Deferred Newly Diagnosed Myeloma

NCT07601100

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions